Literature DB >> 18779047

Malaria parasite pre-erythrocytic stage infection: gliding and hiding.

Ashley M Vaughan1, Ahmed S I Aly, Stefan H I Kappe.   

Abstract

In malaria, the red blood cell-infectious form of the Plasmodium parasite causes illness and the possible death of infected hosts. The initial infection in the liver caused by the mosquito-borne sporozoite parasite stage, however, causes little pathology and no symptoms. Nevertheless, pre-erythrocytic parasite stages are attracting passionate research efforts not least because they are the most promising targets for malaria vaccine development. Here, we review how the infectious sporozoite makes its way to the liver and subsequently develops within hepatocytes. We discuss the factors, both parasite and host, involved in the interactions that occur during this "silent" phase of infection.

Entities:  

Mesh:

Year:  2008        PMID: 18779047      PMCID: PMC2610487          DOI: 10.1016/j.chom.2008.08.010

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  71 in total

Review 1.  In vivo imaging of malaria parasites--recent advances and future directions.

Authors:  Rogerio Amino; Robert Ménard; Freddy Frischknecht
Journal:  Curr Opin Microbiol       Date:  2005-08       Impact factor: 7.934

2.  Quantitative imaging of Plasmodium transmission from mosquito to mammal.

Authors:  Rogerio Amino; Sabine Thiberge; Béatrice Martin; Susanna Celli; Spencer Shorte; Friedrich Frischknecht; Robert Ménard
Journal:  Nat Med       Date:  2006-01-22       Impact factor: 53.440

3.  Distinct malaria parasite sporozoites reveal transcriptional changes that cause differential tissue infection competence in the mosquito vector and mammalian host.

Authors:  Sebastian A Mikolajczak; Hilda Silva-Rivera; Xinxia Peng; Alice S Tarun; Nelly Camargo; Vanessa Jacobs-Lorena; Thomas M Daly; Lawrence W Bergman; Patricia de la Vega; Jack Williams; Ahmed S I Aly; Stefan H I Kappe
Journal:  Mol Cell Biol       Date:  2008-08-18       Impact factor: 4.272

4.  Duration of protection with RTS,S/AS02A malaria vaccine in prevention of Plasmodium falciparum disease in Mozambican children: single-blind extended follow-up of a randomised controlled trial.

Authors:  Pedro L Alonso; Jahit Sacarlal; John J Aponte; Amanda Leach; Eusebio Macete; Pedro Aide; Betuel Sigauque; Jessica Milman; Inacio Mandomando; Quique Bassat; Caterina Guinovart; Mateu Espasa; Sabine Corachan; Marc Lievens; Margarita M Navia; Marie-Claude Dubois; Clara Menendez; Filip Dubovsky; Joe Cohen; Ricardo Thompson; W Ripley Ballou
Journal:  Lancet       Date:  2005-12-10       Impact factor: 79.321

5.  Kupffer cells are obligatory for Plasmodium yoelii sporozoite infection of the liver.

Authors:  Kerstin Baer; Michael Roosevelt; Allen B Clarkson; Nico van Rooijen; Thomas Schnieder; Ute Frevert
Journal:  Cell Microbiol       Date:  2006-08-31       Impact factor: 3.715

6.  L-FABP is a critical host factor for successful malaria liver stage development.

Authors:  Sebastian A Mikolajczak; Vanessa Jacobs-Lorena; Drew C MacKellar; Nelly Camargo; Stefan H I Kappe
Journal:  Int J Parasitol       Date:  2007-01-14       Impact factor: 3.981

7.  Two proteins with 6-cys motifs are required for malarial parasites to commit to infection of the hepatocyte.

Authors:  Tomoko Ishino; Yasuo Chinzei; Masao Yuda
Journal:  Mol Microbiol       Date:  2005-12       Impact factor: 3.501

8.  The liver stage of Plasmodium berghei inhibits host cell apoptosis.

Authors:  Claudia van de Sand; Sebastian Horstmann; Anja Schmidt; Angelika Sturm; Stefanie Bolte; Andreas Krueger; Marc Lütgehetmann; Jörg-Matthias Pollok; Claude Libert; Volker T Heussler
Journal:  Mol Microbiol       Date:  2005-11       Impact factor: 3.501

9.  Plasmodium yoelii sporozoites with simultaneous deletion of P52 and P36 are completely attenuated and confer sterile immunity against infection.

Authors:  Mehdi Labaied; Anke Harupa; Ronald F Dumpit; Isabelle Coppens; Sebastian A Mikolajczak; Stefan H I Kappe
Journal:  Infect Immun       Date:  2007-05-21       Impact factor: 3.441

10.  Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells.

Authors:  Alice S Tarun; Ronald F Dumpit; Nelly Camargo; Mehdi Labaied; Pu Liu; Akihide Takagi; Ruobing Wang; Stefan H I Kappe
Journal:  J Infect Dis       Date:  2007-07-09       Impact factor: 5.226

View more
  47 in total

1.  FLP/FRT-mediated conditional mutagenesis in pre-erythrocytic stages of Plasmodium berghei.

Authors:  Céline Lacroix; Donatella Giovannini; Audrey Combe; Daniel Y Bargieri; Stephan Späth; Dhruv Panchal; Lina Tawk; Sabine Thiberge; Teresa Gil Carvalho; Jean-Christophe Barale; Purnima Bhanot; Robert Ménard
Journal:  Nat Protoc       Date:  2011-08-25       Impact factor: 13.491

2.  Alterations in Phosphorylation of Hepatocyte Ribosomal Protein S6 Control Plasmodium Liver Stage Infection.

Authors:  Elizabeth K K Glennon; Laura S Austin; Nadia Arang; Heather S Kain; Fred D Mast; Kamalakannan Vijayan; John D Aitchison; Stefan H I Kappe; Alexis Kaushansky
Journal:  Cell Rep       Date:  2019-03-19       Impact factor: 9.423

3.  A Malaria-Resistant Phenotype with Immunological Correlates in a Tanzanian Birth Cohort Exposed to Intense Malaria Transmission.

Authors:  Scott D Nash; D Rebecca Prevots; Edward Kabyemela; Yogender P Khasa; Kun-Lin Lee; Michal Fried; Patrick E Duffy
Journal:  Am J Trop Med Hyg       Date:  2017-05       Impact factor: 2.345

4.  The crucial role of hepatocyte growth factor receptor during liver-stage infection is not conserved among Plasmodium species.

Authors:  Alexis Kaushansky; Stefan H I Kappe
Journal:  Nat Med       Date:  2011-10-11       Impact factor: 53.440

5.  Disruption of the Plasmodium falciparum liver-stage antigen-1 locus causes a differentiation defect in late liver-stage parasites.

Authors:  Sebastian A Mikolajczak; John B Sacci; Patricia De La Vega; Nelly Camargo; Kelly VanBuskirk; Urszula Krzych; Jun Cao; Marcelo Jacobs-Lorena; Alan F Cowman; Stefan H I Kappe
Journal:  Cell Microbiol       Date:  2011-06-24       Impact factor: 3.715

Review 6.  Parasite dissemination and the pathogenesis of toxoplasmosis.

Authors:  L M Randall; C A Hunter
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2011-03

7.  Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis.

Authors:  Carola Huthmacher; Andreas Hoppe; Sascha Bulik; Hermann-Georg Holzhütter
Journal:  BMC Syst Biol       Date:  2010-08-31

8.  Malarial parasite pathogenesis and drug targets.

Authors:  Paul D Roepe
Journal:  F1000 Biol Rep       Date:  2009-02-24

9.  Suppression of host p53 is critical for Plasmodium liver-stage infection.

Authors:  Alexis Kaushansky; Albert S Ye; Laura S Austin; Sebastian A Mikolajczak; Ashley M Vaughan; Nelly Camargo; Peter G Metzger; Alyse N Douglass; Gavin MacBeath; Stefan H I Kappe
Journal:  Cell Rep       Date:  2013-03-07       Impact factor: 9.423

10.  The malaria candidate vaccine liver stage antigen-3 is highly conserved in Plasmodium falciparum isolates from diverse geographical areas.

Authors:  Eric Prieur; Pierre Druilhe
Journal:  Malar J       Date:  2009-10-29       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.